Lovelace Biomedical

04/10/2026

Lovelace Biomedical supports preclinical research with the scientific expertise and operational strength sponsors need to move programs forward with confidence.

Lovelace Biomedical in Albuquerque is equipped to tackle preclinical research for everything from gene therapies to infectious disease solutions.

03/26/2026

Lovelace Biomedical Research Institute brings deep expertise across 100+ disease models, pairing rigorous study design with the right endpoints to help you evaluate safety and efficacy with confidence.

Reach out to [email protected] or our Business Development Office
https://www.lovelacebiomedical.org/contact/ to schedule time to discuss your research goals.

03/20/2026

Join Lovelace Biomedical at the Society of Toxicology (SOT) 65th Annual Meeting and ToxExpo this March in San Diego. Visit Booth 1634 to connect with our team and discuss Applied Science, Basic Science, and Toxicology & Drug Development programs designed to help teams make informed decisions across the development lifecycle.

March 22–25, 2026 | San Diego Convention Center
To schedule a meeting: [email protected]

03/18/2026

A stand-alone nonprofit structure creates a clear advantage for long-term scientific partnerships: the ability to prioritize quality, consistency, and responsible research practices without competing commercial interests. At Lovelace Biomedical, that focus is supported by strong operational leadership and decades of experience delivering work that sponsors trust and regulators respect.

Reach out to [email protected] or our Business Development Office
https://www.lovelacebiomedical.org/contact/ to schedule a time to discuss your research goals.

03/13/2026

Our latest publication, “Progress and Promise of Pharmacodynamic Biomarkers: Novel Strategies and Assay Considerations in Drug Development,” examines how pharmacodynamic (PD) biomarkers help researchers better understand a drug’s mechanism of action and measure its biological effects.
https://www.lovelacebiomedical.org/publications/

Reach out to [email protected] or contact our Business Development Office to
schedule a time to discuss your research goals with one of our scientists.
https://www.lovelacebiomedical.org/contact/

03/11/2026

The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit is almost here.
Lovelace Biomedical will be in Salt Lake City this week connecting with leaders across the life sciences and investment communities. If you’ll be attending, we invite you to meet with Dan Garner from our Business Development team to discuss how Lovelace Biomedical supports sponsor programs across toxicology, infectious disease research, and drug development.

March 12–13, 2026 | Salt Lake City, Utah
Reach out to Dan Garner on LinkedIn or email [email protected] to schedule a
meeting.

03/10/2026

Lovelace Biomedical supports infectious disease research with appropriate biosafety capacity and a team approach built for sponsor collaboration.

Reach out to [email protected] or our Business Development Office https://www.lovelacebiomedical.org/contact/ to schedule a time to discuss your research goals.

03/09/2026

Lovelace Biomedical will be attending the 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit in Salt Lake City. This event brings together entrepreneurs, investors, and life sciences leaders to discuss innovation, funding opportunities, and the future of healthcare development.
If you’re attending, connect with Dan Garner from our Business Development team to discuss how
Lovelace Biomedical supports research programs in toxicology, infectious disease, and drug
development.

March 12–13, 2026 | Salt Lake City, Utah
To schedule a meeting with Dan:
Reach out on LinkedIn or email [email protected]

03/03/2026

We’ll be at the Society of Toxicology (SOT) 65th Annual Meeting and ToxExpo in San Diego this March.
Stop by Booth 1634 to connect with Melanie Doyle-Eisele, Andrew Alexander, Dan Garner, and Julie Strickland. We’ll be discussing Applied Science, Basic Science, and Toxicology & Drug Development programs that help teams make clear, confident decisions across the development lifecycle.

March 22–25, 2026 | San Diego Convention Center
To schedule a meeting: [email protected]

02/25/2026

Through our Basic Science research, Lovelace Biomedical helps generate foundational insights that inform applied research, safety evaluation, and therapeutic development. Our scientists bring deep subject-matter expertise and a disciplined research approach to each project, ensuring findings are robust, reproducible, and relevant. Learn more about our research: https://www.lovelacebiomedical.org/

02/17/2026

Lovelace Biomedical is a stand-alone, nonprofit research institute with a singular focus: advancing
science in service of public health and innovation. Our structure allows us to prioritize scientific quality, long-term partnerships, and responsible research practices, without competing commercial interests. With decades of experience and strong operational leadership, we deliver work that sponsors trust and regulators respect.
https://www.lovelacebiomedical.org/

02/12/2026

Lovelace Biomedical supports toxicology and drug development programs with GLP-compliant
capabilities, experienced scientific leadership, and a strong emphasis on data integrity. Our teams help sponsors evaluate safety, refine development pathways, and reduce uncertainty at critical stages. Explore our capabilities: https://www.lovelacebiomedical.org/services/